Enoticumab Biosimilar – Anti-DLL4 mAb – Research Grade

Reference:
Product nameEnoticumab Biosimilar - Anti-DLL4 mAb - Research Grade
SourceCAS 1192578-27-0
SpeciesHomo sapiens
Expression systemMammalian cells
Purity>85%
BufferPBS buffer PH7.5
Delivery conditionBlue ice (+4°C)
Delivery Time3-5 days if in stock; 3-5 weeks if production needed
Storage conditionstore at -80°C
BrandProteoGenix
ApplicationsELISA,WB
Aliases /SynonymsEnoticumab,REGN-421,SAR153192,DLL4 ,anti-DLL4
ReferencePX-TA1291
NoteFor research use only. Not suitable for clinical or therapeutic use.
IsotypeIgG1-kappa
ClonalityMonoclonal Antibody

Description of Enoticumab Biosimilar - Anti-DLL4 mAb - Research Grade

General information on Anti-DLL4 [Homo sapiens] (Enoticumab) Monoclonal Antibody

Enoticumab has been investigated for the treatment of Solid Tumors.

Reviews

There are no reviews yet.

REVIEW YOUR PRODUCT

Be the first to review “Enoticumab Biosimilar – Anti-DLL4 mAb – Research Grade”

Your email address will not be published. Required fields are marked *

Related products

Human DLL4 recombinant protein
Antigen

Human DLL4 recombinant protein

PX-P5121 110€
Human IgG1 LALA Isotype Control antibody (HyHEL-10)
Isotype Control

Human IgG1 LALA Isotype Control antibody (HyHEL-10)

PTX17885 180€
Stable Isotope Labelled Enoticumab Biosimilar – Anti-DLL4  mAb – Research Grade
SIL

Stable Isotope Labelled Enoticumab Biosimilar – Anti-DLL4 mAb – Research Grade

PX-TA1291-SIL 15000€

Contact us

Got a question or need a quote?
Message us and we’ll get back to you 48 hours or less.






    Cart (0 Items)

    Your cart is currently empty.

    View Products